Northpointe Bancshares, Inc.
NYSE:NPBBanks - Regional
+$0.02 today
- Market cap
- $511.47M
- Beta
- 0.11
- P/E (TTM)
- 3.1
- EPS (TTM)
- $5.85
- Dividend yield
- 0.56%
Volume 0.33M
Average 0.15M
NPB Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Northpointe Bancshares, Inc.NYSE: NPB
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 29.88M | — |
Research & Development vs competitors
How NPB compares with its peers on the latest reported figures
- NPB's LTM Mar 2026 research & development of $0 is the lowest of the 7 companies compared; the peer median is $160.83M.
- Research & development amounts to 0.0% of revenue for NPB, versus a peer median of 52.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $378.58M | -9.4% | +7.3% | 27.9% | |
| LTM Jun 2026 | $236.92M | +3.2% | -8.3% | 52.7% | |
| LTM Mar 2026 | $188.07M | +22.3% | +26.8% | — | |
| LTM Sep 2026 | $133.6M | +39.6% | -6.2% | — | |
| LTM Mar 2026 | $101.77M | -11.6% | -4.0% | 291.9% | |
| LTM Mar 2026 | $66.71M | -38.5% | -7.9% | — | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding NPB) | $160.83M | -3.1% | -5.1% | 52.7% | |
Competitors are the stored peer set for NPB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.17M | 324.24M | 362.45M | 390.46M | 471.18M |
| Cost of Revenue | 1.14M | 68.9M | 164.68M | 202.99M | 231.56M |
| Gross Profit | 1.02M | 255.34M | 197.77M | 187.47M | 239.62M |
| Gross Margin | 47.3% | 78.7% | 54.6% | 48.0% | 50.9% |
| Research & Development | 29.88M | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 22.17M | 159.88M | 104.29M | 77.79M | 93.62M |
| Operating Expenses | 52.05M | 221.65M | 153.08M | 114.59M | 129.23M |
| Depreciation & Amortization | 840.94K | 4.02M | 4.02M | 3.8M | 3.07M |
| EBITDA | (56.67M) | 37.71M | 48.7M | 76.68M | 113.47M |
| EBITDA Margin | -2613.5% | 11.6% | 13.4% | 19.6% | 24.1% |
| Operating Income | (51.03M) | 33.69M | 44.69M | 72.88M | 110.39M |
| Operating Margin | -2353.1% | 10.4% | 12.3% | 18.7% | 23.4% |
| Interest Income | 525.54K | 166.12M | 267.38M | 317.53M | 380.2M |
| Interest Expense | 0 | 66.69M | 166.16M | 203.32M | 229.47M |
| Other Income / Expenses | (6.49M) | 0 | 0 | 0 | 0 |
| Income Before Tax | (57.52M) | 33.69M | 44.69M | 72.88M | 110.39M |
| Pre-Tax Margin | -2652.3% | 10.4% | 12.3% | 18.7% | 23.4% |
| Income Tax Expense | (77.7K) | 10.46M | 10.93M | 17.72M | 26.98M |
| Net Income | (57.44M) | 23.24M | 33.76M | 55.16M | 83.41M |
| Net Margin | -2648.7% | 7.2% | 9.3% | 14.1% | 17.7% |
| EPS (Basic) | (1.74) | 0.92 | 1.61 | 3.15 | 4.92 |
| EPS (Diluted) | (1.74) | 0.92 | 1.61 | 3.15 | 4.85 |
| Weighted Avg Shares | 33.03M | 14.92M | 14.92M | 14.92M | 14.54M |
| Weighted Avg Shares (Diluted) | 33.03M | 14.92M | 14.92M | 14.92M | 14.72M |
Northpointe Bancshares, Inc.
NYSE:NPB
Intrinsic Alpha fair value
Locked
Current Price
$14.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.